Company Filing History:
Years Active: 2004-2017
Title: Glenn Croston: Innovator in Serotonergic Treatments
Introduction
Glenn Croston is a notable inventor based in San Diego, CA, with a focus on advancements in the field of serotonergic treatments. He holds a total of 4 patents that contribute to the understanding and treatment of various disease conditions.
Latest Patents
Among his latest patents are methods of treatment using selective 5-HT2A inverse agonists. These compounds and methods are designed for the treatment of disease conditions where modification of serotonergic receptor activity can have a beneficial effect. In this method, an effective amount of a compound is administered to a patient in need of such treatment. Another significant patent involves azacyclic compounds, which also aim to treat disease conditions through similar mechanisms of serotonergic receptor activity modification.
Career Highlights
Glenn Croston is currently associated with Acadia Pharmaceuticals Inc., where he continues to innovate and develop new therapeutic methods. His work is pivotal in advancing the understanding of serotonergic systems and their implications in various health conditions.
Collaborations
He collaborates with esteemed colleagues such as Carl-Magnus A Andersson and Eva Louise Hansen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Glenn Croston's contributions to the field of serotonergic treatments through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic approaches that can improve patient outcomes.